AU2003227362A8 - Method of examining atopic dermatitis - Google Patents

Method of examining atopic dermatitis

Info

Publication number
AU2003227362A8
AU2003227362A8 AU2003227362A AU2003227362A AU2003227362A8 AU 2003227362 A8 AU2003227362 A8 AU 2003227362A8 AU 2003227362 A AU2003227362 A AU 2003227362A AU 2003227362 A AU2003227362 A AU 2003227362A AU 2003227362 A8 AU2003227362 A8 AU 2003227362A8
Authority
AU
Australia
Prior art keywords
atopic dermatitis
examining
examining atopic
dermatitis
atopic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003227362A
Other versions
AU2003227362A1 (en
Inventor
Hajime Sudo
Hideoki Ogawa
Chisei Ra
Kouichi Mitsuishi
Mikito Itoh
Akira Shinagawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genox Research Inc
Juntendo University
Original Assignee
Genox Research Inc
Juntendo University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genox Research Inc, Juntendo University filed Critical Genox Research Inc
Publication of AU2003227362A8 publication Critical patent/AU2003227362A8/en
Publication of AU2003227362A1 publication Critical patent/AU2003227362A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/713—Double-stranded nucleic acids or oligonucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6881—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from skin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
AU2003227362A 2002-08-06 2003-04-24 Method of examining atopic dermatitis Abandoned AU2003227362A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002229320 2002-08-06
JP2002-229320 2002-08-06
PCT/JP2003/005277 WO2004016783A1 (en) 2002-08-06 2003-04-24 Method of examining atopic dermatitis

Publications (2)

Publication Number Publication Date
AU2003227362A8 true AU2003227362A8 (en) 2004-03-03
AU2003227362A1 AU2003227362A1 (en) 2004-03-03

Family

ID=31884339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003227362A Abandoned AU2003227362A1 (en) 2002-08-06 2003-04-24 Method of examining atopic dermatitis

Country Status (3)

Country Link
JP (1) JPWO2004016783A1 (en)
AU (1) AU2003227362A1 (en)
WO (1) WO2004016783A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR061669A1 (en) 2006-06-29 2008-09-10 Merz Pharma Gmbh & Co Kgaa HIGH FREQUENCY THERAPY APPLICATION WITH BOTULIN TOXIN

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003180356A (en) * 1999-07-09 2003-07-02 Mitsubishi Chemicals Corp Atopy gene
AU2001238347A1 (en) * 2000-02-28 2001-09-12 Hyseq, Inc. Novel nucleic acids and polypeptides
JP2002095500A (en) * 2000-09-25 2002-04-02 Jenokkusu Soyaku Kenkyusho:Kk Method for examining allergic disease

Also Published As

Publication number Publication date
JPWO2004016783A1 (en) 2006-01-19
AU2003227362A1 (en) 2004-03-03
WO2004016783A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
GB0325192D0 (en) Method of use
GB0228326D0 (en) Method of controlling unwanted vegitation
EP1577280A4 (en) Method of deuterization
GB0306309D0 (en) Method of treatment
GB0302572D0 (en) Method of treatment
EP1488046A4 (en) Method of construction
EP1491091A4 (en) Insect-proofing means and method of insect-proofing
GB0303936D0 (en) Method of testing
AU2003252418A8 (en) Method of examining atopic dermatitis
GB0312561D0 (en) Apparatus and method of using same
AU2003227362A8 (en) Method of examining atopic dermatitis
AU2003288762A1 (en) Method and apparatus of hemorheometer
AU2003252326A8 (en) Method of examining atopic dermatitis
GB0208897D0 (en) New method of treatment
EP1688503A4 (en) Method of treating cells
GB0323788D0 (en) Apparatus and method of using the same
GB0326088D0 (en) Method of spectroscopy
EP1650563A4 (en) Method of judging fatigue
GB0213198D0 (en) Method of treatment
EP1669390A4 (en) Polyaminopyridines and method for producing same
GB0202048D0 (en) Method of treating atopic dermatitis
GB0209122D0 (en) The treatment of atopic dermatitis
GB0207091D0 (en) Method of treatment
AU2002329587A1 (en) Method for the treatment of atopic dermatitis
GB0329688D0 (en) Method of insulation

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 18, NO 15, PAGE(S) 4448 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME GENOXRESEARCH, INC., APPLICATION NO. 2003227362, UNDER INID (71) CORRECT THE NAME TO READ JUNTENDO UNIVERSITY; GENOX RESEARCH, INC.